GSK PLC (fka GlaxoSmithKline PLC)
| Industry | Status | Date | Ticker(s) | issuer(s) | MO | SP | FI | Size (M) | Ranking | TNR | Call | MTY | Coupon | Leads | product | Region | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HLTH | PRCD | Sep 8, 2026 | GSK | GlaxoSmithKline Capital Inc | A2 | A | - | $1,250 | Sr. Unsecured | 3.00 | - | Sep-29 | 4.850% | IGC | USOA | ||||
HLTH | PRCD | Sep 8, 2026 | GSK | GlaxoSmithKline Capital Inc | A2 | A | - | $500 | Sr. Unsecured | 3.00 | - | Sep-29 | SOFR+56 | IGC | USOA | ||||
HLTH | PRCD | Sep 8, 2026 | GSK | GlaxoSmithKline Capital Inc | A2 | A | - | $1,250 | Sr. Unsecured | 5.00 | - | Sep-31 | 5.10% | IGC | USOA | ||||
HLTH | PRCD | Sep 8, 2026 | GSK | GlaxoSmithKline Capital Inc | A2 | A | - | $1,500 | Sr. Unsecured | 7.00 | - | Sep-33 | 5.25% | IGC | USOA | ||||
HLTH | PRCD | Sep 8, 2026 | GSK | GlaxoSmithKline Capital Inc | A2 | A | - | $1,500 | Sr. Unsecured | 10.00 | - | Sep-36 | 5.50% | IGC | USOA | ||||
HLTH | PRCD | Sep 8, 2026 | GSK | GlaxoSmithKline Capital Inc | A2 | A | - | $500 | Sr. Unsecured | 30.00 | - | Sep-56 | 6.05% | IGC | USOA | ||||
HLTH | PRCD | Aug 27, 2026 | GSK | GSK Capital BV | A2 | A | - | €850 | Sr. Unsecured | 1.50 | - | Mar-28 | 3mEu+30 | IGC | EMEA | ||||
HLTH | PRCD | Aug 27, 2026 | GSK | GSK Capital BV | A2 | A | - | €1,000 | Sr. Unsecured | 4.00 | - | Sep-30 | 3.50% | IGC | EMEA | ||||
HLTH | PRCD | Aug 27, 2026 | GSK | GSK Capital BV | A2 | A | - | €850 | Sr. Unsecured | 8.00 | - | Sep-34 | 3.875% | IGC | EMEA | ||||
HLTH | PRCD | Aug 27, 2026 | GSK | GSK Capital BV | A2 | A | - | €800 | Sr. Unsecured | 11.00 | - | Sep-37 | 4.125% | IGC | EMEA |